Clinical Trials in Illinois

Showing 2681-2700 of 9,411 trials

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

NCT03858634

Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study. The diseases characterized by chronic pruritus investigated in this pilot study currently include chronic idiopathic urticaria (CIU), chronic idiopathic pruritus (CIP), lichen planus (LP), lichen simplex chronicus (LSC) and plaque psoriasis (PPs).

Chronic Idiopathic UrticariaChronic Idiopathic PruritusLichen Planus+2 more

Genentech, Inc.58 participantsStarted May 2019

Anniston, Alabama, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +11 more locations

Active Not RecruitingNA42 miles

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

NCT03298477

Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System.

Abdominal Aortic Aneurysm Without Rupture

Endologix98 participantsStarted Dec 2017

Huntsville, Alabama, United States • Los Angeles, California, United States • San Diego, California, United States +24 more locations

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Find Trials by Condition in Illinois

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

BIOTRONIK Conduction System Pacing With the Solia Lead

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

SNV1521 in Participants with Advanced Solid Tumors

HPV Vaccine Intervention for Young Sexual Minority Men

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

A Study of LY3561774 in Participants With Mixed Dyslipidemia

Precision Study Measuring Potassium (K) in Capillary Specimens

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay